Metagenomi Therapeutics, Inc. (MGX) › RevenueMetagenomi Therapeutics, Inc. (MGX) — RevenueAnnual figures by fiscal year, from SEC filings.2023: $44.76M2024: $52.30M2025: $25.21M$25.21M2023Revenue (USD)2025Fiscal YearRevenueChange YoY2025$25.21M-51.8%2024$52.30M+16.8%2023$44.76M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share